EFFICACY AND SAFETY OF ABALOPARATIDE IN POSTMENOPAUSAL WOMEN AT HIGH RISK OF FRAGILITY FRACTURE

被引：0
|
作者：
Harvey, N. C. [1 ]
机构：
[1] Univ Southampton, Southampton Gen Hosp, MRC Lifecourse Epidemiol Ctr, Southampton SO16 6YD, Hants, England
来源：
AGING CLINICAL AND EXPERIMENTAL RESEARCH | 2023年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
SY9
引用
收藏
页码：S581 / S581
页数：1
相关论文
共 50 条
  • [21] Effect of Abaloparatide on Bone Mineral Density and Fracture Incidence in a Subset of Younger Postmenopausal Women with Osteoporosis at High Risk for Fracture (vol 42, pg 1099, 2020)
    Saag, Kenneth G.
    Williams, Setareh A.
    Wang, Yamei
    Weiss, Richard J.
    Cauley, Jane A.
    CLINICAL THERAPEUTICS, 2020, 42 (10) : 2117 - 2117
  • [22] The Safety and Efficacy of Abaloparatide on Postmenopausal Osteoporosis: A Systematic Review and Meta-analysis
    Xu, Fuxin
    Wang, Yurun
    Zhu, Xinjian
    CLINICAL THERAPEUTICS, 2024, 46 (03) : 267 - 274
  • [23] EFFICACY AND SAFETY IN THE USE OF ROMOSOZUMAB IN POSTMENOPAUSAL WOMEN WITH SEVERE OSTEOPOROSIS AT HIGH RISK OF FRACTURE IN AN OUTPATIENT CASE SERIES FROM THE MARCHE REGION
    Farina, A.
    Pingiotti, E.
    Martino, G. P.
    Bitti, G.
    Angelici, S.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2024, 36 : S120 - S120
  • [24] THE FRAGILITY FRACTURE PHENOTYPE - A 611 OSTEOPOROTIC POSTMENOPAUSAL WOMEN STUDY
    Poiana, C.
    Carsote, M.
    Radoi, V.
    Samoila, R.
    Ene, C.
    Barbu, C.
    Fica, S.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 298 - 298
  • [25] RELATIONSHIP BETWEEN BMI AND FRAGILITY FRACTURE IN BOSNIAN POSTMENOPAUSAL WOMEN
    Kapetanovic, A.
    Mesanovic, E.
    Avdic, D.
    Turkic, E.
    Zulcic, E.
    Sokolovic, S.
    OSTEOPOROSIS INTERNATIONAL, 2020, 31 (SUPPL 1) : S234 - S235
  • [26] Utility of fragility fracture prediction tools in a group of postmenopausal women
    Amarowicz, Jaroslaw
    Krawczyk, Agnieszka
    Kumorek, Anna
    REUMATOLOGIA, 2021, 59 (04): : 230 - 236
  • [27] Effect of Abaloparatide vs Alendronate on Fracture Risk Reduction in Postmenopausal Women With Osteoporosis (vol 105, pg 938, 2020)
    Leder, B. Z.
    Mitlak, B.
    Hu, M.
    Hattersley, G.
    Bockman, R. S.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (08): : E3053 - E3053
  • [28] HIGH VEGETABLE INTAKE IS ASSOCIATED WITH LOWER FRAGILITY FRACTURE RATE IN POSTMENOPAUSAL ELDERLY TAIWANESE WOMEN
    Hsu, Hung-Chih
    Lin, Chu-Hsu
    JOURNAL OF AGING AND PHYSICAL ACTIVITY, 2012, 20 : S185 - S186
  • [29] Fracture risk assessment in postmenopausal women
    Hamdy, Ronald C.
    REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2010, 11 (04): : 229 - 236
  • [30] Identifying fracture risk in postmenopausal women
    Mehler, PS
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (09): : 1109 - 1110
12345